These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 36142483)
1. Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease. Al-Ghraiybah NF; Wang J; Alkhalifa AE; Roberts AB; Raj R; Yang E; Kaddoumi A Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142483 [TBL] [Abstract][Full Text] [Related]
2. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models. Lantz MJ; Roberts AM; Delgado DD; Nichols RA J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024 [TBL] [Abstract][Full Text] [Related]
3. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons. Moonen S; Koper MJ; Van Schoor E; Schaeverbeke JM; Vandenberghe R; von Arnim CAF; Tousseyn T; De Strooper B; Thal DR Acta Neuropathol; 2023 Feb; 145(2):175-195. PubMed ID: 36481964 [TBL] [Abstract][Full Text] [Related]
4. Role of Microglia and Astrocytes in Alzheimer's Disease: From Neuroinflammation to Ca Di Benedetto G; Burgaletto C; Bellanca CM; Munafò A; Bernardini R; Cantarella G Cells; 2022 Sep; 11(17):. PubMed ID: 36078138 [TBL] [Abstract][Full Text] [Related]
5. The effects of microglia-associated neuroinflammation on Alzheimer's disease. Wang C; Zong S; Cui X; Wang X; Wu S; Wang L; Liu Y; Lu Z Front Immunol; 2023; 14():1117172. PubMed ID: 36911732 [TBL] [Abstract][Full Text] [Related]
6. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach. Rodriguez-Vieitez E; Kumar A; Malarte ML; Ioannou K; Rocha FM; Chiotis K Methods Mol Biol; 2024; 2785():195-218. PubMed ID: 38427196 [TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles. Ghosh P; Singh R; Ganeshpurkar A; Pokle AV; Singh RB; Singh SK; Kumar A Neurochem Int; 2021 Dec; 151():105212. PubMed ID: 34656693 [TBL] [Abstract][Full Text] [Related]
9. Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches. Yassaghi Y; Nazerian Y; Ghasemi M; Nazerian A; Sayehmiri F; Perry G; Gholami Pourbadie H J Cell Mol Med; 2024 Aug; 28(15):e18554. PubMed ID: 39103747 [TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics. Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874 [TBL] [Abstract][Full Text] [Related]
11. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches. Ahmad MH; Fatima M; Mondal AC J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170 [TBL] [Abstract][Full Text] [Related]
12. NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease. Van Zeller M; Dias D; Sebastião AM; Valente CA J Alzheimers Dis; 2021; 83(3):939-961. PubMed ID: 34366341 [TBL] [Abstract][Full Text] [Related]
13. Role of Chemokines in the Development and Progression of Alzheimer's Disease. Wojcieszak J; Kuczyńska K; Zawilska JB J Mol Neurosci; 2022 Sep; 72(9):1929-1951. PubMed ID: 35821178 [TBL] [Abstract][Full Text] [Related]
14. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice. Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120 [TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease: Is there a role for galectins? da Rosa MM; de Aguiar Ferreira M; de Oliveira Lima CA; Santos Mendonça AC; Silva YM; Sharjeel M; de Melo Rego MJB; Pereira MC; da Rocha Pitta MG Eur J Pharmacol; 2021 Oct; 909():174437. PubMed ID: 34450113 [TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies. Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119 [TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease. Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759 [TBL] [Abstract][Full Text] [Related]
18. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease. Kaur D; Sharma V; Deshmukh R Inflammopharmacology; 2019 Aug; 27(4):663-677. PubMed ID: 30874945 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy? Melchiorri D; Merlo S; Micallef B; Borg JJ; Dráfi F Front Pharmacol; 2023; 14():1196413. PubMed ID: 37332353 [TBL] [Abstract][Full Text] [Related]
20. Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer's Disease. Yan H; Wang W; Cui T; Shao Y; Li M; Fang L; Feng L Immunotargets Ther; 2024; 13():287-304. PubMed ID: 38881647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]